Ai Hua Ong

Ai Hua Ong
Ai Hua joined Johnson & Johnson more than 25 years ago with a desire to make a difference to the lives of patients. This passion continues today in her role as Company Group Chairman for Janssen Asia Pacific, where she oversees operations that deliver pharmaceutical innovation in Australia, China, Hong Kong, India, Japan, Korea, New Zealand and Taiwan. Based in her native Singapore, Ai Hua is known for her deep commitment to customers and patients, her strategic insights and global mindset. She is a strong advocate for women in leadership and provides guidance and support through local universities and the …
Ai Hua joined Johnson & Johnson more than 25 years ago with a desire to make a difference to the lives of patients. This passion continues today in her role as Company Group Chairman for Janssen Asia Pacific, where she oversees operations that deliver pharmaceutical innovation in Australia, China, Hong Kong, India, Japan, Korea, New Zealand and Taiwan.

Based in her native Singapore, Ai Hua is known for her deep commitment to customers and patients, her strategic insights and global mindset. She is a strong advocate for women in leadership and provides guidance and support through local universities and the Young Women’s Leadership Connection Mentorship Program.

In her previous role as President of One J&J Southeast Asia, Ai Hua was instrumental in the successful implementation of J&J’s first-ever one-company enterprise business model encompassing pharmaceuticals, consumer products and medical devices. She nurtured a business with strong growth and enhanced efficiency across 10 countries in ASEAN.

Ai Hua holds a BSc in Microbiology and Biochemistry and an MBA from the National University of Singapore. She began her healthcare career in 1991 as a product specialist with Johnson & Johnson Medical Singapore. Since then, she has held leadership roles in pharmaceuticals and medical devices working in strategic marketing, sales management, and licensing and acquisition while residing in Singapore, China and the USA.

Ai Hua is a committed volunteer for charitable causes and acts as chair of J&J’s Asia Pacific Contributions Committee. She is also a council member of the Singapore Dover Park Hospice, serves on the Advisory Board of the Singapore Management University Lee Kong Chian School of Business, and was recently appointed to the Board of the DesignSingapore Council.
See more

Articles: Ai Hua Ong

Decision Time for APAC Pharma: Step Up or Sit Back?

Asia-Pacific / Ai Hua Ong, Asia-Pacific company group chairman of Janssen, the Pharmaceutical Companies of Johnson & Johnson, looks back at the tremendous progress the pharmaceutical industry has made in the Asia-Pacific region over the last ten years and highlights how the industry needs to adapt to meet emergent challenges.   By any measure, the last ten…

Diversity, Inclusion and Addressing Unconscious Bias

Diversity / Ai Hua Ong, Company Group Chairman, Asia Pacific, The Janssen Pharmaceutical Companies of Johnson & Johnson.   There is a clear correlation between an inclusive culture and innovation Creating a diverse workforce and an inclusive culture is key to an organisation’s success in today’s and tomorrow’s world. Organisations large and small are embracing what we…

Turkey: The Future of Cancer Care Uncertain

Cancer / Turkey has one of the most revered Social Security Systems in the world, providing its citizens with free healthcare and access to a long list of innovative cancer drugs. However, with one of the youngest populations in Europe, the sustainability of the system is uncertain as its incredibly young population gets older and incidence of cancer increases.…

See more